Resources

Report

  • 2021–2024 HIV Market Intelligence Report

    The 2021–2024 HIV Market Intelligence Report examines the procurement, pricing and regulatory environments for antiretroviral medicines in six countries: Argentina,...

  • Senegal’s medicine & vaccines supply systems in HIV, TB, HPV & cancer areas

    A new market intelligence study by Enda Santé, KELIN and ITPC, conducted as part of the Make Medicines Affordable campaign,...

  • Evergreening During an Emergency

    Evergreening During an Emergency, a report from Make Medicines Affordable, provides a comprehensive epidemiological and clinical overview of mpox, and covers patent landscaping for mpox vaccines and potential treatments.

  • World Community Advisory Board Meeting Report 2023

    Please find all the details of the World Community Advisory Board Meeting Report for 2023 below.

  • Compulsory Licensing in Eighteen Middle-Income Countries

    This study provides an analysis of provisions related to compulsory licensing (CL); it was created to assess their utility and...

  • Pre-exposure HIV prophylaxis in Russia: market analysis for 2022

    The incidence and prevalence of HIV infection, as well as HIV mortality in Russia are among the highest among the...

  • Access to COVID-19 Vaccines From Oxford/AstraZeneca, Johnson and Johnson, Moderna and Pfizer/BioNTech in 17 Middle-Income Countries

    A Report From the Make Medicines Affordable Campaign   The report assesses and provides detailed information on the availability and...

  • Barreras Legales en Guatemala de la Propiedad Intelectual

    Estudio sobre Barreras Legales en Guatemala de la Propiedad Intelectual aplicada a la adquisición de medicamentos ARV para VIH.

  • 8° Informe Nacional sobre Derechos Humanos de las personas con VIH

    8° Informe Nacional sobre Derechos Humanos de las personas con VIH y las poblaciones en más alto riesgo a la...

  • Estudio Comparativo de las Leyes de Propiedad Industrial en El Salvador, Guatemala y Honduras

  • Почему в Украине необходима патентная реформа в сфере лекарственных средств

    Жесткая система защиты патентных прав в Украине значительно препаятствует доступности лекраственных средств для населения. Использование гибких положений Соглашения ТРИПС будет...

  • Отчет о ТРИПС+ в Украине

    В рамках данного исследования будут раскрыты три механизма, целью которых является усиление защиты прав производителей оригинальных препаратов, а именно продление...